Jonathan Wolff, Alfred Landecker Professor of Values and Public Policy, is among the authors of 'What are the obligations of pharmaceutical companies in a global health emergency?' published in The Lancet.
The article explores the moral obligations of pharmaceutical companies during a pandemic. All parties involved in researching, developing, manufacturing, and distributing COVID-19 vaccines need guidance on their ethical obligations. The authors focus on pharmaceutical companies' obligations because their capacities to research, develop, manufacture, and distribute vaccines make them uniquely placed for stemming the pandemic.
The authors state "an ethical approach to COVID-19 vaccine production and distribution should satisfy four uncontroversial principles: optimising vaccine production, including development, testing, and manufacturing; fair distribution; sustainability; and accountability."